Article Contents ::
- 1 Details About Generic Salt :: Magaldra
- 2 Main Medicine Class:: Antacid
- 3 (MAG-al-drate) Iosopan, Riopan, Riopan Extra Strength Class: Antacid
- 4 Drugs Class ::
- 5 Disclaimer ::
- 6 The Information available on this site is for only Informational Purpose , before any use of this information please consult your Doctor .Price of the drugs indicated above may not match to real price due to many possible reasons may , including local taxes etc.. These are only approximate indicative prices of the drug.
Details About Generic Salt :: Magaldra
Main Medicine Class:: Antacid
(MAG-al-drate)
Iosopan, Riopan, Riopan Extra Strength
Class: Antacid
Drugs Class ::
Action Neutralizes gastric acid, thereby increasing pH of stomach and duodenal bulb. Increases lower esophageal sphincter tone and inhibits smooth muscle contraction and gastric emptying.
Indications for Drugs ::
Indications Symptomatic relief of upset stomach associated with hyperacidity, including heartburn, gastroesophageal reflux, acid indigestion and sour stomach; relief of hyperacidity associated with peptic ulcer, gastritis, peptic esophagitis, gastric hyperacidity and hiatal hernia.
Drug Dose ::
Route/Dosage
ADULTS: PO 480–1080 mg qid prn or to aid in peptic ulcer healing or chronic reflux, give 1 hr and 3 hr after meals and at bedtime (7 doses/day). CHILDREN: PO 5–10 mg/dose q 3–6 hr or 1 hr and 3 hr after meals and at bedtime for peptic ulcer.
Contraindication ::
Contraindications Severe renal dysfunction; hypophosphatemia; nausea; vomiting; severe abdominal pain; acute surgical abdomen; impaction; intestinal obstruction.
Drug Precautions ::
Precautions
Pregnancy: Pregnancy category undetermined. Lactation: Undetermined. GI hemorrhage: Use with care in patients with recent massive upper GI hemorrhage. Renal insufficiency: Use with caution in patients with renal impairment to avoid hypermagnesemia and toxicity.
PATIENT CARE CONSIDERATIONS |
|
Drug Side Effects ::
Adverse Reactions
CNS: Neurotoxicity; encephalopathy. GI: Diarrhea; constipation; intestinal obstruction; rebound hyperacidity. META: Hypophosphatemia; hypermagnesemia. OTHER: Osteomalacia; bone pain; muscular weakness; malaise; decreased fluoride absorption; aluminum accumulation in serum, bone and CNS; milk-alkali syndrome.
Drug Mode of Action ::
Action Neutralizes gastric acid, thereby increasing pH of stomach and duodenal bulb. Increases lower esophageal sphincter tone and inhibits smooth muscle contraction and gastric emptying.
Drug Interactions ::
Interactions
Iron: Decreased pharmacologic effect of iron. Ketoconazole: Decreased pharmacologic effect of ketoconazole. Nitrofurantoin: Decreased effects of nitrofurantoin. Penicillamine: Decreased pharmacologic effect of penicillamine. Quinidine: Increased pharmacologic effect of quinidine. Quinolones: Decreased pharmacologic effect of quinolones. Salicylates: Decreased pharmacologic effect of salicylates. Sodium polystyrene sulfonate: Concomitant use may cause metabolic alkalosis in patients with renal failure. Tetracyclines: Decreased pharmacologic effect of tetracyclines.
Drug Assesment ::
Assessment/Interventions
- Obtain patient history, including drug history and any allergies.
- Assess for heartburn and indigestion, noting location, duration, character and precipitating factors of GI pain.
- Monitor serum magnesium level in patients with renal impairment.
- Monitor level of relief obtained by patient following medication.
|
Drug Storage/Management ::
Administration/Storage
- Administer 1 hr and 3 hr after meals and at bedtime when ordered for treatment of ulcers or 4 times/day when ordered as necessary for relief of symptoms.
- If possible, administer antacid 1–2 hr before or after other medications.
- Shake suspension vigorously before pouring. Administer with sufficient water (approximately 4 oz) to ensure that drug reaches stomach.
- Chewable tablet should be chewed thoroughly before swallowing, followed by half a glass of water.
- Store at room temperature.
Drug Notes ::
Patient/Family Education
- Instruct patient to take medication 1 and 3 hr after meals and at bedtime.
- Warn patient not to take other medications within 2 hr of antacid.
- Review proper use of suspension or tablet form.
- Advise patient to consult physician if problem recurs, if any symptoms that suggest bleeding occur (eg, black tarry stools) or if patient has taken antacids for more than 2 wk.